|
KMID : 0606920150230020201
|
|
Biomolecules & Therapeutics
2015 Volume.23 No. 2 p.201 ~ p.206
|
|
|
Effects of Baicalin on Oral Pharmacokinetics of Caffeine in Rats
|
|
Noh Keum-Han
Nepal Mahesh Raj
Jeong Ki-Sun
Kim Sun-A
Um Yeon-Ji
Seo Chae-Shin
Kang Mi-Jeong
Park Pil-Hoon
Kang Won-Ku
Jeong Hye-Gwang
Jeong Tae-Cheon
|
|
|
Abstract
|
|
|
|
Scutellaria baicalensis is one of the most widely used herbal medicines in East Asia. Because baicalein and baicalin are major components of this herb, it is important to understand the effects of these compounds on drug metabolizing enzymes, such as cytochrome P450 (CYP), for evaluating herb-drug interaction. The effects of baicalin and baicalein on activities of ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), benzyloxyresorufin O-debenzylase (BROD), p-nitrophenol hydroxylase and erythromycin N-demethylase were assessed in rat liver microsomes in the present study. In addition, the pharmacokinetics of caffeine and its three metabolites (i.e., paraxanthine, theobromine and theophylline) in baicalin-treated rats were compared with untreated control. As results, EROD, MROD and BROD activities were inhibited by both baicalin and baicalein. However, there were no significant differences in the pharmacokinetic parameters of oral caffeine and its three metabolites between control and baicalin-treated rats. When the plasma concentration of baicalin was determined, the maximum concentration of baicalin was below the estimated IC50 values observed in vitro. In conclusion, baicalin had no effects on the pharmacokinetics of caffeine and its metabolites in vivo, following single oral administration in rats.
|
|
|
KEYWORD
|
|
|
Baicalin, Baicalein, Caffeine, Drug interaction, Pharmacokinetics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|
|